iifl-logo

Ranbaxy Laboratories Ltd Merged Cash Flow Statement

859.8
(5.63%)
Apr 1, 2015|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ranbaxy Laboratories Ltd Merged FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2014Dec-2012

Profit before tax

-366.88

216.94

Depreciation

-280.17

-186.16

Tax paid

-30.57

1.94

Working capital

-1,471.1

Other operating items

Operating

-2,148.72

Capital expenditure

242.47

Free cash flow

-1,906.25

Equity raised

3,475.14

Investing

949.71

Financing

9,104.3

Dividends paid

0

0

Net in cash

11,622.89

Ranbaxy Laboratories Ltd Merged : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.